Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,194,910
-
Total 13F shares
-
6,494,302
-
Share change
-
+1,475,079
-
Total reported value
-
$46,629,314
-
Price per share
-
$7.18
-
Number of holders
-
56
-
Value change
-
+$11,145,137
-
Number of buys
-
38
-
Number of sells
-
17
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q2 2025
As of 30 Jun 2025,
Journey Medical Corp - Common Stock (DERM) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,494,302 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, WASATCH ADVISORS LP, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, AMERICAN FINANCIAL GROUP INC, UBS Group AG, and PVG ASSET MANAGEMENT CORP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.